111 related articles for article (PubMed ID: 25122418)
1. Practice makes perfect protocols: the Canadian anaplastic lymphoma kinase study.
Yoshida A
J Thorac Oncol; 2014 Sep; 9(9):1237-9. PubMed ID: 25122418
[No Abstract] [Full Text] [Related]
2. Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer.
Cutz JC; Craddock KJ; Torlakovic E; Brandao G; Carter RF; Bigras G; Deschenes J; Izevbaye I; Xu Z; Greer W; Yatabe Y; Ionescu D; Karsan A; Jung S; Fraser RS; Blumenkrantz M; Lavoie J; Fortin F; Bojarski A; Côté GB; van den Berghe JA; Rashid-Kolvear F; Trotter M; Sekhon HS; Albadine R; Tran-Thanh D; Gorska I; Knoll JH; Xu J; Blencowe B; Iafrate AJ; Hwang DM; Pintilie M; Gaspo R; Couture C; Tsao MS
J Thorac Oncol; 2014 Sep; 9(9):1255-63. PubMed ID: 25122422
[TBL] [Abstract][Full Text] [Related]
3. Adding bevacizumab to chemotherapy effectively control radioresistant brain metastases in ALK-positive lung adenocarcinoma.
Su YL; Rau KM
J Thorac Oncol; 2015 Apr; 10(4):e21-2. PubMed ID: 25789840
[No Abstract] [Full Text] [Related]
4. Comprehensive Hybrid Capture-Based Next-Generation Sequencing Identifies a Double ALK Gene Fusion in a Patient Previously Identified to Be False-Negative by FISH.
Heuckmann JM; Pauwels P; Thunnissen E
J Thorac Oncol; 2017 Mar; 12(3):e22-e24. PubMed ID: 28215724
[No Abstract] [Full Text] [Related]
5. Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma.
Caumont C; Veillon R; Gros A; Laharanne E; Bégueret H; Merlio JP
Lung Cancer; 2016 Feb; 92():15-8. PubMed ID: 26775590
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological features of lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements].
Dong Y; Zhou L; Wang J; Cai Y; Mu J; Zhang H
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):436-40. PubMed ID: 26463147
[TBL] [Abstract][Full Text] [Related]
7. ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.
Marchetti A; Di Lorito A; Pace MV; Iezzi M; Felicioni L; D'Antuono T; Filice G; Guetti L; Mucilli F; Buttitta F
J Thorac Oncol; 2016 Apr; 11(4):487-95. PubMed ID: 26916631
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.
Cha YJ; Kim HR; Shim HS
J Transl Med; 2016 Oct; 14(1):296. PubMed ID: 27756333
[TBL] [Abstract][Full Text] [Related]
9. [Expression of ALK protein in 7 371 pulmonary adenocarcinoma samples, with analysis of clinicopathologic features].
Zhao RY; Zhang J; Zhu L; Shao JC; Zhang Q; Teng HH; Qin G; Zhao LX; Ye M; Zhao JK; Ding WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):601-5. PubMed ID: 27646887
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic Lymphoma Kinase Immunocytochemistry on Cell-Transferred Cytologic Smears of Lung Adenocarcinoma.
Zhang C; Randolph ML; Jones KJ; Cramer HM; Cheng L; Wu HH
Acta Cytol; 2015; 59(2):213-8. PubMed ID: 25967762
[TBL] [Abstract][Full Text] [Related]
11. ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice.
Martin V; Bernasconi B; Merlo E; Balzarini P; Vermi W; Riva A; Chiaravalli AM; Frattini M; Sahnane N; Facchetti F; Mazzucchelli L; Sessa F; Tibiletti MG
J Thorac Oncol; 2015 Apr; 10(4):595-602. PubMed ID: 25514802
[TBL] [Abstract][Full Text] [Related]
12. [Crizotinib treatment in a lung adenocarcinoma harboring ALK fusion gene with bone marrow metastasis: case report and literature review].
Li X; Liu X; Gao F; Yin X
Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):85-8. PubMed ID: 25676401
[TBL] [Abstract][Full Text] [Related]
13. Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report.
Shirasawa M; Kubotaa M; Harada S; Niwa H; Kusuhara S; Kasajima M; Hiyoshi Y; Ishihara M; Igawa S; Masuda N
Lung Cancer; 2016 Sep; 99():66-8. PubMed ID: 27565916
[TBL] [Abstract][Full Text] [Related]
14. ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features.
Possidente L; Landriscina M; Patitucci G; Borgia L; Lalinga V; Vita G
Med Oncol; 2017 May; 34(5):76. PubMed ID: 28364271
[TBL] [Abstract][Full Text] [Related]
15. Changes in Immunohistochemical Protein Levels in Anaplastic Lymphoma Kinase-positive Lung Adenocarcinoma Possibly due to Chemo-radiotherapy.
Taniguchi H; Ikeda T; Soda H; Fukuda Y; Kitazaki T; Nakamura Y; Kohno S
Intern Med; 2016; 55(13):1775-8. PubMed ID: 27374682
[TBL] [Abstract][Full Text] [Related]
16. Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative.
Ma D; Wang Z; Yang L; Mu X; Wang Y; Zhao X; Li J; Lin D
Oncotarget; 2016 Sep; 7(39):64410-64420. PubMed ID: 27418132
[TBL] [Abstract][Full Text] [Related]
17. ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma.
Muscarella LA; Trombetta D; Fabrizio FP; Scarpa A; Fazio VM; Maiello E; Rossi A; Graziano P
J Thorac Oncol; 2017 Oct; 12(10):e161-e163. PubMed ID: 28939148
[No Abstract] [Full Text] [Related]
18. ALK positivity on pleuroscopic pleural biopsy in lung adenocarcinoma.
Vaidya PJ; Kate AH; Mehta D; Dhabar BN; Chhajed PN
J Cancer Res Ther; 2016; 12(2):1090-2. PubMed ID: 27461706
[TBL] [Abstract][Full Text] [Related]
19. High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients.
Zhang Z; Ye S; Zhang M; Wu J; Yan H; Li X; He J
Tumour Biol; 2017 Jul; 39(7):1010428317720212. PubMed ID: 28720066
[TBL] [Abstract][Full Text] [Related]
20. Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
Zito Marino F; Liguori G; Aquino G; La Mantia E; Bosari S; Ferrero S; Rosso L; Gaudioso G; De Rosa N; Scrima M; Martucci N; La Rocca A; Normanno N; Morabito A; Rocco G; Botti G; Franco R
PLoS One; 2015; 10(9):e0139264. PubMed ID: 26422230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
